Furthermore, VD3 attenuated the activation of Protein kinase B (Akt) while suppressing the expression of cysteine-rich angiogenic inducer 61 (CYR61) and connective tissue growth factor (CTGF), thus indicating anti-tumor effects. The gene discussed is CCN1; the disease is neoplasm.